Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

By Thompson H.S.G.   Davies M.L.   Holding F.P.   Fallon R.E.   Mann A.E.   O'Neill T.   St Clair Roberts J.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 40-49

Elsevier

Access to resources Recommend Favorite

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects

By Squarcione S.   Sgricia S.   Biasio L.R.   Perinetti E.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1268-1274

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

By De Donato S.   Granoff D.   Minutello M.   Lecchi G.   Faccini M.   Agnello M.   Senatore F.   Verweij P.   Fritzell B.   Podda A.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3094-3101

Elsevier

Access to resources Recommend Favorite

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

By Gilbert S.C.   Schneider J.   Hannan C.M.   Hu J.T.   Plebanski M.   Sinden R.   Hill A.V.S.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1039-1045

Elsevier

Access to resources Recommend Favorite

Increased immunogenicity of HIV envelope subunit complexed with 2 -macroglobulin when combined with monophosphoryl lipid A and GM-CSF

By Liao H.-X.   Cianciolo G.J.   Staats H.F.   Scearce R.M.   Lapple D.M.   Stauffer S.H.   Thomasch J.R.   Pizzo S.V.   Montefiori D.C.   Hagen M.   Eldridge J.   Haynes B.F.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2396-2403

Elsevier

Access to resources Recommend Favorite